NexImmune Appoints Sol Barer as Chairman of the Board of Directors

NEXT STORY
Salarius Pharmaceuticals Receives FDA Fast Track Designation for Lead Drug Candidate, Seclidemstat, in Relapsed or Refractory Ewing Sarcoma
PREV STORY
BeiGene Announces Results of Phase 3 ASPEN Trial of Zanubrutinib Compared to Ibrutinib for the Treatment of Patients with Waldenström’s Macroglobulinemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hopewell Therapeutic Farm Community Receives Extension To Its Nationally Recognized CARF Accreditation

CLEVELAND, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Hopewell Therapeutic Farm Community has just received ...

author_avatar
NASDAQ Market News

CymaBay Therapeutics Announces the Publication of the Seladelpar Proof-of-Concept Study for Primary Biliary Cholangitis in Lancet Gastroenterology and Hepatology

NEWARK, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage ...

author_avatar
NASDAQ Market News

Novelion Therapeutics Announces Leadership Change

Novelion General Counsel Benjamin Harshbarger Appointed as Interim Chief Executive Officer (CEO) VANCOUVER, British ...

author_avatar
NASDAQ Market News